Peritoneal Carcinomatosis Treated With Surgery And Intraperitoneal Chemohyperthermia: 14 Years Experience In Lyon
The Internet Journal of Medical Technology · 2004
DOI: 10.5580/cd9 ↗At a glance
Journal article in The Internet Journal of Medical Technology, 2004.
Abstract (original language)
In the past, carcinomatosis from non gynaecologic malignancies has been regarded as a terminal disease, most oncologists have regarded it as a condition only to be palliated. Literature concerning the natural history of this condition is not extensive. However, three studies document a median survival of approximately 6 months.1,2,3 Research protocols using palliative systemic chemotherapy have been conducted with encouraging tumour response rates, but with no improvement in survival rates.2,4,5 In the 1980s, a renewed interest in peritoneal surface malignancies developed in an attempt to find benefit for patients through new multimodal therapeutic approaches. Publications regarding previously unexplored treatment options such as peritonectomy procedures,6 intraperitoneal injection of anticancer drug OK432,7 intracavitary immunotherapy, 7
Cite
APA
(2004). Peritoneal Carcinomatosis Treated With Surgery And Intraperitoneal Chemohyperthermia: 14 Years Experience In Lyon. The Internet Journal of Medical Technology. https://doi.org/10.5580/cd9
Vancouver
Peritoneal Carcinomatosis Treated With Surgery And Intraperitoneal Chemohyperthermia: 14 Years Experience In Lyon. The Internet Journal of Medical Technology. 2004. doi:10.5580/cd9
BibTeX
@article{euvimed2004,
title = {Peritoneal Carcinomatosis Treated With Surgery And Intraperitoneal Chemohyperthermia: 14 Years Experience In Lyon},
journal = {The Internet Journal of Medical Technology},
year = {2004},
doi = {10.5580/cd9}
}
EUVIMED